NO951646L - Nye merkaptoacetylamid-bisykliske laktamderivater som er anvendbare som inhibitorer av enkefalinase og ACE - Google Patents

Nye merkaptoacetylamid-bisykliske laktamderivater som er anvendbare som inhibitorer av enkefalinase og ACE

Info

Publication number: NO951646L
Authority: NO; Norway
Prior art keywords: enkephalinase; ace; inhibitors; derivatives useful; biscyclic
Prior art date: 1992-10-30

Application number

NO951646A

Other languages

English (en)

Norwegian (no)

Other versions

NO951646D0 (no

Inventor

Gary Alan Flynn

Original Assignee

Merrell Dow Pharma

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1992-10-30

Filing date

1995-04-28

Publication date

1995-06-23

1995-04-28 Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma

1995-04-28 Publication of NO951646D0 publication Critical patent/NO951646D0/no

1995-06-23 Publication of NO951646L publication Critical patent/NO951646L/no

Links

102000003729 Neprilysin Human genes 0.000 title abstract 2
108090000028 Neprilysin Proteins 0.000 title abstract 2
239000003112 inhibitor Substances 0.000 title abstract 2
GYXHHICIFZSKKZ-UHFFFAOYSA-N 2-sulfanylacetamide Chemical compound NC(=O)CS GYXHHICIFZSKKZ-UHFFFAOYSA-N 0.000 title 1
150000003951 lactams Chemical class 0.000 title 1
229910052739 hydrogen Inorganic materials 0.000 abstract 3
239000001257 hydrogen Substances 0.000 abstract 3
125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 3
125000005869 (methoxyethoxy)methanyl group Chemical group [H]C([H])([H])OC([H])([H])C([H])([H])OC([H])([H])* 0.000 abstract 1
125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 abstract 1
125000000217 alkyl group Chemical group 0.000 abstract 1
125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 abstract 1
125000005982 diphenylmethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])(*)C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 abstract 1
-1 mercaptoacetylamide bicyclic lactam Chemical class 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06139—Dipeptides with the first amino acid being heterocyclic
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/55—Protease inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Immunology (AREA)
Biomedical Technology (AREA)
Genetics & Genomics (AREA)
Molecular Biology (AREA)
Biophysics (AREA)
Biochemistry (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Ophthalmology & Optometry (AREA)
Diabetes (AREA)
Transplantation (AREA)
Psychiatry (AREA)
Pain & Pain Management (AREA)
Urology & Nephrology (AREA)
Endocrinology (AREA)
Heart & Thoracic Surgery (AREA)
Hematology (AREA)
Cardiology (AREA)
Hospice & Palliative Care (AREA)
Gastroenterology & Hepatology (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

NO951646A 1992-10-30 1995-04-28 Nye merkaptoacetylamid-bisykliske laktamderivater som er anvendbare som inhibitorer av enkefalinase og ACE NO951646L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US96877092A	1992-10-30	1992-10-30
PCT/US1993/009001 WO1994010193A1 (fr)	1992-10-30	1993-09-23	Nouveaux derives de lactame bicyclique de mercaptoacetylamide utiles, comme inhibiteurs de l'encephalinase et de l'eca

Publications (2)

Publication Number	Publication Date
NO951646D0 NO951646D0 (no)	1995-04-28
NO951646L true NO951646L (no)	1995-06-23

Family

ID=25514751

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO951646A NO951646L (no)	1992-10-30	1995-04-28	Nye merkaptoacetylamid-bisykliske laktamderivater som er anvendbare som inhibitorer av enkefalinase og ACE

Country Status (21)

Country	Link
US (1)	US5635502A (fr)
EP (1)	EP0669936B1 (fr)
JP (1)	JP3420766B2 (fr)
KR (1)	KR100311166B1 (fr)
AT (1)	ATE197714T1 (fr)
AU (1)	AU673857B2 (fr)
CA (1)	CA2146238C (fr)
DE (1)	DE69329701T2 (fr)
DK (1)	DK0669936T3 (fr)
ES (1)	ES2155852T3 (fr)
FI (1)	FI110263B (fr)
GR (1)	GR3035416T3 (fr)
HU (1)	HUT71243A (fr)
IL (1)	IL107413A (fr)
MX (1)	MX9306758A (fr)
NO (1)	NO951646L (fr)
NZ (1)	NZ256589A (fr)
PT (1)	PT669936E (fr)
TW (1)	TW327172B (fr)
WO (1)	WO1994010193A1 (fr)
ZA (1)	ZA937912B (fr)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5552397A (en) *	1992-05-18	1996-09-03	E. R. Squibb & Sons, Inc.	Substituted azepinone dual inhibitors of angiotensin converting enzyme and neutral exdopeptidase
US5504080A (en) *	1992-10-28	1996-04-02	Bristol-Myers Squibb Co.	Benzo-fused lactams
US5654294A (en) *	1993-05-13	1997-08-05	Bristol-Myers Squibb	Spiro lactam dual action inhibitors
JP3563738B2 (ja) *	1993-06-11	2004-09-08	エーザイ株式会社	アミノ酸誘導体
US5508272A (en) *	1993-06-15	1996-04-16	Bristol-Myers Squibb Company	Compounds containing a fused bicycle ring and processes therefor
US5525723A (en) *	1993-11-18	1996-06-11	Bristol-Myers Squibb Co.	Compounds containing a fused multiple ring lactam
HUT74385A (en) *	1994-02-14	1996-12-30	Merrell Pharma Inc	Novel mercaptoacetylamido 1,3,4,5-tetrahydro-benzo[c]azepin-3-one disulfide derivatives useful as inhibitors of enkephalinase and ace
CN1142831A (zh) *	1994-02-14	1997-02-12	默里尔药物公司	用作脑啡肽酶和ace抑制剂的新的2-取代的1，2-二氢化茚-2-巯基乙酰胺二硫化物衍生物
HUT74584A (en) *	1994-02-14	1997-01-28	Merrell Pharma Inc	Novel heterocycle fused benzazepine-2-mercaptoacetylamide disulfide derivatives useful as inhibitors of enkephalinase, process for producing them and pharmaceutical compositions containing them
JP3444666B2 (ja)	1994-08-24	2003-09-08	エーザイ株式会社	（２ｓ，３ｓ）−３− メチル−２− チオペンタン酸誘導体の製造方法
US5789403A (en) *	1994-07-18	1998-08-04	Eisai Co., Ltd.	Substituted thiazolo 3,2-a!azepine derivatives
US5587375A (en) *	1995-02-17	1996-12-24	Bristol-Myers Squibb Company	Azepinone compounds useful in the inhibition of ACE and NEP
US6245764B1 (en)	1995-03-24	2001-06-12	Molecumetics Ltd.	β-sheet mimetics and use thereof as inhibitors of biologically active peptides or proteins
US6020331A (en) *	1995-03-24	2000-02-01	Molecumetics, Ltd.	β-sheet mimetics and use thereof as protease inhibitors
US6699869B1 (en)	1995-03-24	2004-03-02	Myriad Genetics Inc.	β-sheet mimetics and use thereof as inhibitors of biologically active peptides or proteins
US5877313A (en)	1995-05-17	1999-03-02	Bristol-Myers Squibb	Benzo-fused azepinone and piperidinone compounds useful in the inhibition of ACE and NEP
US5650408A (en) *	1995-06-07	1997-07-22	Karanewsky; Donald S.	Thiazolo benzazepine containing dual action inhibitors
US5635504A (en) *	1995-06-07	1997-06-03	Bristol-Myers Squibb Co.	Diazepine containing dual action inhibitors
DE69926750T2 (de)	1998-06-17	2006-06-29	Bristol-Myers Squibb Co.	Vorbeugung des hirninfarkts durch kombinierte verabreichung von adp-rezeptor antiblutplättchen und antihypertensiven medikamenten
CA2368026A1 (fr) *	1999-03-22	2000-09-28	Bi-Huang Hu	Banques combinatoires d'oxazole et de thiazole
US7015212B1 (en)	1999-05-12	2006-03-21	The United States Of America As Represented By The Department Of Health And Human Services	Thiazepine inhibitors of HIV-1 integrase
JP2005526722A (ja)	2002-02-14	2005-09-08	ミリアド・ジェネティックス・インコーポレイテッド	β−シートミメティックならびにそれに関連する組成物および方法
FR2984716B1 (fr)	2011-12-22	2013-12-27	Essilor Int	Dispositif et procede de determination d'au moins un parametre de refraction oculaire objective d'un sujet en fonction d'une pluralite de directions de regard
JP6382831B2 (ja)	2012-11-30	2018-08-29	サンフォード−バーンハムメディカルリサーチインスティテュート	アポトーシス阻害タンパク質（ｉａｐ）のアンタゴニスト
CA2950911C (fr)	2014-06-04	2023-10-10	Sanford-Burnham Medical Research Institute	Utilisation d'un inhibiteur des antagonistes de la proteine d'apoptose (iap) dans une therapie contre le vih
US10513515B2 (en)	2017-08-25	2019-12-24	Biotheryx, Inc.	Ether compounds and uses thereof
CA3106239A1 (fr)	2018-07-27	2020-01-30	Biotheryx, Inc.	Composes bifonctionnels agissant par agonisme sur des cdk
EP4143329A4 (fr)	2020-04-28	2024-10-16	Anwita Biosciences, Inc.	Polypeptides d'interleukine-2 et protéines de fusion de ceux-ci, ainsi que leurs compositions pharmaceutiques et leurs applications thérapeutiques

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3334095A (en) *	1965-02-16	1967-08-01	Sandoz Ag	Novel pyrrolo-oxazines and pyrrolo-oxazoles
US3334091A (en) *	1965-03-25	1967-08-01	Sandoz Ag	Sedatives
GB1525845A (en) *	1976-07-30	1978-09-20	Ucb Sa	1,2,4,5-tetrahydro-3h-2-benzazepin-3-ones
IE50839B1 (en) *	1980-02-26	1986-07-23	Wyeth John & Brother Ltd	Novel processes for preparing proline derivatives and analogous compounds
EP0042100A1 (fr) *	1980-06-13	1981-12-23	F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft	Dérivés de la pyrazolopyridazine, intermédiaires et leur procédés de préparation, et médicaments les contenant
US4320057A (en) *	1980-06-23	1982-03-16	American Home Products Corporation	Aryl--pyrrolo--thiazepin--diones and aryl--piperidino--thiazepin--diones
US4415496A (en) *	1981-03-23	1983-11-15	Merck & Co., Inc.	Bicyclic lactams
GB2128984B (en) *	1982-05-12	1985-05-22	Hoffmann La Roche	Diaza-bicyclic compounds
ZA833214B (en) *	1982-05-12	1983-12-28	Hoffmann La Roche	Bicyclic compounds
US4552889A (en) *	1983-06-09	1985-11-12	Eli Lilly And Company	3-Mercaptomethyl-2-oxo-1-pyrrolidine acetic acids and use for hypertension
US4692438A (en) *	1984-08-24	1987-09-08	Hoffmann-La Roche Inc.	Pyridazo-diazepines, diazocines, and -triazepines having anti-hypertensive activity
US4584294A (en) *	1984-11-07	1986-04-22	Merck & Co., Inc.	Fused tricyclic lactams as angiotensin converting enzyme inhibitors and as antihypertensive agents
PT82468B (en) *	1985-04-30	1988-03-23	Lilly Co Eli	Process for preparing 7-substituted bycyclic pyrazolidinones
ES2061490T3 (es) *	1986-04-04	1994-12-16	Sankyo Co	Derivados de perhidrotiazepina y perhidroazepina, su preparacion y uso en terapeutica.
ZA874106B (en) *	1986-06-13	1987-12-08	Merrell Dow Pharmaceuticals Inc.	Novel antihypertensive agent
ZA874107B (fr) *	1986-06-13	1987-12-09
US4973585A (en) *	1986-06-13	1990-11-27	Merrell Dow Pharmaceuticals	Tricyclic lactams active as antihypertensive agents
GB8629875D0 (en) *	1986-12-15	1987-01-28	Hoffmann La Roche	Pyridazodiazepine derivatives
US4824832A (en) *	1987-12-30	1989-04-25	Merrell Dow Pharmaceuticals Inc.	Sulfhydryl containing tricyclic lactams and their pharmacological methods of use
GB8926512D0 (en) *	1989-11-23	1990-01-10	Pfizer Ltd	Therapeutic agents
AU7168091A (en) *	1989-12-22	1991-07-24	Schering Corporation	Mercaptocycloacyl aminoacid endopeptidase inhibitors
CA2053340C (fr) *	1990-10-18	2002-04-02	Timothy P. Burkholder	Derives de mercaptoacetylamide utiles comme inhibiteurs de l'encephalinase et de l'ace
US5208230A (en) *	1990-12-21	1993-05-04	Merrell Dow Pharmaceuticals	Amino and nitro containing tricyclic compounds useful as inhibitors of ACE
AU642321B2 (en) *	1990-12-21	1993-10-14	Merrell Pharmaceuticals Inc.	Novel amino and nitro containing tricyclic compounds useful as inhibitors of ace
FR2679564A1 (fr) *	1991-07-23	1993-01-29	Inst Nat Sante Rech Med	Nouveaux acylmercaptoalcanoldipeptides, leur preparation et les compositions qui les contiennent.
EP0605589A1 (fr) *	1991-09-16	1994-07-13	Schering Corporation	Compositions pharmaceutiques comprenant des peptides natriuretiques ou des inhibiteurs d'endopeptidase neutres utilises dans le traitement ou la prevention de la proliferation dans la myointima
GB9204588D0 (en) *	1992-03-03	1992-04-15	Ferguson Scot Ltd	Containers
US5238932A (en) *	1992-05-20	1993-08-24	Merrell Dow Pharmaceuticals Inc.	Mercaptoacetylamide tricyclic derivatives useful as inhibitors of enkephalinase
US5362727A (en) *	1993-07-26	1994-11-08	Bristol-Myers Squibb	Substituted azepino[2,1-a]isoquinoline compounds

1993
- 1993-09-23 CA CA002146238A patent/CA2146238C/fr not_active Expired - Lifetime
- 1993-09-23 DK DK94914243T patent/DK0669936T3/da active
- 1993-09-23 US US08/406,979 patent/US5635502A/en not_active Expired - Lifetime
- 1993-09-23 HU HU9501239A patent/HUT71243A/hu unknown
- 1993-09-23 EP EP94914243A patent/EP0669936B1/fr not_active Expired - Lifetime
- 1993-09-23 NZ NZ256589A patent/NZ256589A/en not_active IP Right Cessation
- 1993-09-23 PT PT94914243T patent/PT669936E/pt unknown
- 1993-09-23 AT AT94914243T patent/ATE197714T1/de active
- 1993-09-23 DE DE69329701T patent/DE69329701T2/de not_active Expired - Lifetime
- 1993-09-23 WO PCT/US1993/009001 patent/WO1994010193A1/fr not_active Ceased
- 1993-09-23 KR KR1019950701668A patent/KR100311166B1/ko not_active Expired - Fee Related
- 1993-09-23 ES ES94914243T patent/ES2155852T3/es not_active Expired - Lifetime
- 1993-09-23 AU AU51362/93A patent/AU673857B2/en not_active Expired
- 1993-09-23 JP JP51105294A patent/JP3420766B2/ja not_active Expired - Fee Related
- 1993-10-25 ZA ZA937912A patent/ZA937912B/xx unknown
- 1993-10-26 TW TW082108885A patent/TW327172B/zh not_active IP Right Cessation
- 1993-10-27 IL IL10741393A patent/IL107413A/en not_active IP Right Cessation
- 1993-10-29 MX MX9306758A patent/MX9306758A/es unknown
1995
- 1995-04-27 FI FI952014A patent/FI110263B/fi not_active IP Right Cessation
- 1995-04-28 NO NO951646A patent/NO951646L/no not_active Application Discontinuation
2001
- 2001-02-14 GR GR20010400246T patent/GR3035416T3/el unknown

Also Published As

Publication number	Publication date
HUT71243A (en)	1995-11-28
HU9501239D0 (en)	1995-06-28
IL107413A (en)	1999-08-17
DE69329701D1 (de)	2000-12-28
MX9306758A (es)	1994-07-29
WO1994010193A1 (fr)	1994-05-11
GR3035416T3 (en)	2001-05-31
DE69329701T2 (de)	2001-05-10
IL107413A0 (en)	1994-01-25
ZA937912B (en)	1994-06-01
AU5136293A (en)	1994-05-24
EP0669936B1 (fr)	2000-11-22
JP3420766B2 (ja)	2003-06-30
FI952014L (fi)	1995-04-27
EP0669936A1 (fr)	1995-09-06
DK0669936T3 (da)	2001-02-05
ES2155852T3 (es)	2001-06-01
CA2146238A1 (fr)	1994-05-11
NO951646D0 (no)	1995-04-28
TW327172B (en)	1998-02-21
KR950704349A (ko)	1995-11-20
FI952014A0 (fi)	1995-04-27
KR100311166B1 (ko)	2002-02-28
ATE197714T1 (de)	2000-12-15
NZ256589A (en)	1996-05-28
PT669936E (pt)	2001-04-30
FI110263B (fi)	2002-12-31
JPH08502746A (ja)	1996-03-26
CA2146238C (fr)	2001-03-13
AU673857B2 (en)	1996-11-28
US5635502A (en)	1997-06-03

Legal Events

Date	Code	Title	Description
2003-10-13	FC2A	Withdrawal, rejection or dismissal of laid open patent application

Publication	Publication Date	Title
NO951646L (no)	1995-06-23	Nye merkaptoacetylamid-bisykliske laktamderivater som er anvendbare som inhibitorer av enkefalinase og ACE
AU563683B2 (en)	1987-07-16	Substituted acyl derivative of 1,2,3,4-tetrahydroiso- quinoline-3-carboxylic acid
NO881326L (no)	1988-09-27	Acetylener som er disubstituert med en fenylgruppe og en heterobicyklisk gruppe med retinoidliknende aktivitet.
ES2186672T3 (es)	2003-05-16	Procedimiento para la produccion de derivados 13-eter de milbemicinas, e intermedios de los mismos.
DK0620215T3 (da)	1999-12-06	1H-indol-3-acetamidderivater som sPLA2-inhibitorer
NO951266L (no)	1995-10-02	Imidazol-holdige inhibitorer for farnesyl-protein-transferase
NO943093L (no)	1994-12-09	Fremgangsmåte for fremstilling av clavulansyre
NO177300C (no)	1995-08-23	Analogifremgangsmåte for fremstilling av et kinolinderivat og mellomprodukter
NO952289L (no)	1995-06-09	Substituerte benzazepinoner
IE43847L (en)	1976-11-16	N-substituted phenylpiperidine derivatives.
NO960441L (no)	1996-02-02	Benzopyraner og farmasöytiske forbindelser inneholdende dem
NO933837L (no)	1993-10-25	4-aryl-3-(heteroarylureido)kinolin-derivater
UA43338C2 (uk)	2001-12-17	Похідні бензолу
MY131544A (en)	2007-08-30	Fluorinated 4-aminoandrostadienone derivatives and process for their preparation
TW340844B (en)	1998-09-21	Amide derivatives
TW336232B (en)	1998-07-11	Indol-3-yl propenoic acid derivatives for antagonizing NMDA(N-methyl-D-aspartate) and pharmaceutical compositions thereof
EA199900460A1 (ru)	2000-02-28	Производные бензолсульфоамида и лекарственные средства, содержащие упомянутые производные
NO942896L (no)	1994-08-04	Nye syreanhydrider, deres fremstilling og anvendelse
AU2742288A (en)	1989-06-29	Novel compound effective as cerebral insufficiency improver
TW218379B (en)	1994-01-01	Hydroxymethylpolythiophene derivative
ES8404989A1 (es)	1984-05-16	Un procedimiento para preparar 4-(2-hidroxietil)-2-azetidinona opticamente activa.